Literature DB >> 23795873

Impact of cannabis use during stabilization on methadone maintenance treatment.

Jillian L Scavone1, Robert C Sterling, Stephen P Weinstein, Elisabeth J Van Bockstaele.   

Abstract

BACKGROUND AND OBJECTIVES: Illicit drug use, particularly of cannabis, is common among opiate-dependent individuals and has the potential to impact treatment in a negative manner.
METHODS: To examine this, patterns of cannabis use prior to and during methadone maintenance treatment (MMT) were examined to assess possible cannabis-related effects on MMT, particularly during methadone stabilization. Retrospective chart analysis was used to examine outpatient records of patients undergoing MMT (n = 91), focusing specifically on past and present cannabis use and its association with opiate abstinence, methadone dose stabilization, and treatment compliance.
RESULTS: Objective rates of cannabis use were high during methadone induction, dropping significantly following dose stabilization. History of cannabis use correlated with cannabis use during MMT but did not negatively impact the methadone induction process. Pilot data also suggested that objective ratings of opiate withdrawal decrease in MMT patients using cannabis during stabilization. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: The present findings may point to novel interventions to be employed during treatment for opiate dependence that specifically target cannabinoid-opioid system interactions.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795873      PMCID: PMC4717827          DOI: 10.1111/j.1521-0391.2013.12044.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  51 in total

1.  Marijuana use by methadone maintenance patients.

Authors:  A J Saxon; D A Calsyn; P A Blaes; V M Haver; D M Greenberg
Journal:  NIDA Res Monogr       Date:  1990

2.  Coping strategies and continued drug use among methadone maintenance patients.

Authors:  M A Belding; M Y Iguchi; R J Lamb; M Lakin; R Terry
Journal:  Addict Behav       Date:  1996 May-Jun       Impact factor: 3.913

3.  Marijuana use by heroin abusers as a factor in program retention.

Authors:  M Ellner
Journal:  J Consult Clin Psychol       Date:  1977-08

4.  Marijuana and benzodiazepines in patients receiving methadone treatment.

Authors:  R L DuPont; K E Saylor
Journal:  JAMA       Date:  1989-06-16       Impact factor: 56.272

5.  Nonnarcotic drug use over an addiction career--a study of heroin addicts in Baltimore and New York City.

Authors:  D N Nurco; T W Kinlock; T E Hanlon; J C Ball
Journal:  Compr Psychiatry       Date:  1988 Sep-Oct       Impact factor: 3.735

6.  Long-term methadone maintenance treatment: some clinical examples.

Authors:  S P Weinstein; E Gottheil; R C Sterling; P A DeMaria
Journal:  J Subst Abuse Treat       Date:  1993 May-Jun

7.  Diminished illicit drug use as a consequence of long-term methadone maintenance.

Authors:  E Gottheil; R C Sterling; S P Weinstein
Journal:  J Addict Dis       Date:  1993

8.  Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.

Authors:  R C Frederickson; C R Hewes; J W Aiken
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

9.  Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.

Authors:  L San; M Torrens; C Castillo; M Porta; R de la Torre
Journal:  Addiction       Date:  1993-10       Impact factor: 6.526

10.  Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine.

Authors:  G Vela; M Ruiz-Gayo; J A Fuentes
Journal:  Neuropharmacology       Date:  1995-06       Impact factor: 5.250

View more
  31 in total

1.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.

Authors:  Marcus A Bachhuber; Brendan Saloner; Chinazo O Cunningham; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

2.  No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Am J Addict       Date:  2015-04-06

3.  Marijuana use and achievement of abstinence from alcohol and other drugs among people with substance dependence: a prospective cohort study.

Authors:  Mohammadali Mojarrad; Jeffrey H Samet; Debbie M Cheng; Michael R Winter; Richard Saitz
Journal:  Drug Alcohol Depend       Date:  2014-06-18       Impact factor: 4.492

4.  High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Authors:  Maria Eugenia Socías; Evan Wood; Stephanie Lake; Seonaid Nolan; Nadia Fairbairn; Kanna Hayashi; Hennady P Shulha; Seagle Liu; Thomas Kerr; M-J Milloy
Journal:  Addiction       Date:  2018-09-20       Impact factor: 6.526

Review 5.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

6.  The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.

Authors:  Adam Bisaga; Maria A Sullivan; Andrew Glass; Kaitlyn Mishlen; Martina Pavlicova; Margaret Haney; Wilfrid N Raby; Frances R Levin; Kenneth M Carpenter; John J Mariani; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2015-07-08       Impact factor: 4.492

7.  Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth.

Authors:  Scott E Hadland; Evan Wood; Ekaterina Nosova; Thomas Kerr; Kora DeBeck
Journal:  J Adolesc Health       Date:  2017-09-01       Impact factor: 5.012

8.  The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada.

Authors:  Jenna Valleriani; Rebecca Haines-Saah; Rielle Capler; Ricky Bluthenthal; M Eugenia Socias; M J Milloy; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-11

9.  Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.

Authors:  Heather McBrien; Candice Luo; Nitika Sanger; Laura Zielinski; Meha Bhatt; Xi Ming Zhu; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  CMAJ Open       Date:  2019-11-19

10.  Variability in medical marijuana laws in the United States.

Authors:  Jessica Bestrashniy; Ken C Winters
Journal:  Psychol Addict Behav       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.